XML 100 R87.htm IDEA: XBRL DOCUMENT v3.22.2.2
Financial Instruments - Narrative (Details) - USD ($)
3 Months Ended 9 Months Ended
Oct. 01, 2022
Oct. 02, 2021
Oct. 01, 2022
Oct. 02, 2021
Dec. 31, 2021
Financial Instruments          
Accounts receivable, reserves $ 31,600,000   $ 31,600,000   $ 35,500,000
Investments in equity securities without readily determinable fair values 18,200,000   18,200,000   15,400,000
Cumulative impairment 10,000,000   10,000,000   10,000,000
Impairment loss       $ 1,000,000  
Interest expense 24,800,000 $ 22,600,000 74,600,000 67,200,000  
Derivative contracts classified within Level 3 of fair value hierarchy 0   0   0
Derivative contracts transfers in to Level 3 fair value hierarchy     0    
Asset impairment charges     5,700,000 2,000,000  
Russia-Ukraine Conflict          
Financial Instruments          
Asset impairment charges 19,900,000   4,400,000    
E-Systems          
Financial Instruments          
Impairment of intangible assets     8,900,000 8,500,000  
Kongsberg ICS          
Financial Instruments          
Right of use asset 34,100,000   34,100,000    
Kongsberg ICS | Level 3 | Estimated aggregate fair value          
Financial Instruments          
Property, plant and equipment 124,100,000   124,100,000    
Intangible assets 11,100,000   11,100,000    
Interest Rate Swap | Net investment hedge contracts | Designated as Hedging Instrument          
Financial Instruments          
Interest expense     4,100,000 $ 4,900,000  
Foreign currency contracts | Designated as Hedging Instrument | Derivative Instruments and Hedging          
Financial Instruments          
Pretax gains (losses) related to derivative instruments and hedging activities in accumulated other comprehensive loss $ 40,800,000   $ 40,800,000   $ (16,100,000)